Brentwood, Tenn.-based Surgery Partners continues to expand its ASC portfolio while navigating reimbursement pressure, labor costs and strategic growth opportunities.
Here are 10 things to know so far in 2025:
- Surgery Partners reported $776 million in revenue in the first quarter of 2025, up 8.2% from $717.4 million in Q1 2024.
- Adjusted earnings before interest, taxes, depreciation and amortization in Q1 was $103.9 million, up from $97.5 million in the same period last year.
- Same-facility revenue grew 5.2% and case volume 6.5% year over year in Q1, reflecting strong organic growth.
- The company recorded a net loss of $37.7 million in Q1, compared to a net loss of $12.4 million in Q1 2024.
- As of March 31, Surgery Partners had $229.3 million in cash and equivalents and a net debt-to-EBITDA ratio of 4.1x.
- In the second quarter of 2025, Surgery Partners reported $826.6 million in revenue, an 8.4% year-over-year increase.
- Same-facility revenue grew 5.1% and cases rose 3.4% in Q2, while revenue per case increased 1.6%.
- Adjusted EBITDA in Q2 was $129 million, up 9% from the prior year.
- The company posted a net loss of $2.5 million in Q2, compared with $15.5 million in Q2 2024.
10. Surgery Partners reaffirmed its full-year 2025 guidance of $3.3 billion to $3.45 billion in revenue and $555 million to $565 million in adjusted EBITDA.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
